ÌÚ²©»á¹ÙÍø


TEL:17312606166£¨É¡Ë¾Àí£©

VRͼ±ê°×É« VRͼ±êÐþÉ«
X

ÌÚ²©»á¹ÙÍøÁÙ´²Ç°´ó¶¯ÎïʵÑéÖÐÐÄ

ÓëÎÒÃÇÈ¡µÃÁªÏµ

    17312606166

·ÎÑо¿¶¯ÎïÄ£×Ó

ÄúµÄλÖãºÊ×Ò³ >> ÐÐÒµ¶¯Ì¬ >> ×ÊѶ

Ìý˵ £¬±ïÆø30Ãë £¬¿ÉÒÔÅжÏÄãµÄ·ÎÊÇ·ñ¿µ½¡ ¡£

¿ìÀ´¼ì²âһϣ¡ÏÖÔÚ £¬×îÏȱïÆø £¬Ö±µ½Ô²µã´ÓAµãµÖ´ïBµã ¡£

image.png

(ͼƬÀ´×ÔÍøÂç)

ʲô£¿Ã»Óмá³Öµ½30Ã룡

ÄÇÎÒºÜÒź¶µÄ¸æËßÄú £¬Õâ¸öЧ¹û²¢²»¿ÉÕæʵ·´Ó¦ÄúµÄ·Î²¿¿µ½¡×´Ì¬£¨¶¥¹øÅÜ£©~Ö»ÄÜ˵Ã÷ £¬ÄúµÄ·Î»îÁ¿½ÏС £¬ÊDz»ÊÇÁ¼¾ÃûÔ˶¯À²£¿

ËäÈ»ÕâÒ»²âÊÔÎÞ·¨ÅжϷεĿµ½¡×´Ì¬ £¬µ«ÄãÊÇ·ñ¸ÐÊܵ½Á˺ôÎüµÄÖ÷ÒªÐÔ ¡£Ê±Ê±¿Ì¿Ì £¬ÐÂÏʵĿÕÆøÕýͨ¹ýÆø¹Ü½øÈëÎÂůµÄÐØÇ» £¬ÆäÖеÄÑõÆø´Ó·ÎÖÐÂ˳ö £¬Ëæ×ÅѪҺ±¼Ïò´óÄÔ £¬ËÄÖ«¡­

½ñÌì £¬ÎÒÃDZãÀ´ÏÈÈÝÏÂÈËÌåºôÎüÖÐÊࡪ¡ª·Î £¬Ö÷Òª°üÀ¨ËüµÄ½á¹¹ £¬Ï¸°ûÀàÐÍ £¬Ïà¹ØÖØ´ó¼²²¡¼°¶¯ÎïÄ£×Ó ¡£

·ÎµÄÐÄÀí½á¹¹

Õý³£µÄ·Î³ÊdzºìÉ« £¬Î»ÓÚÐØÇ» £¬ÁýÕÖÔÚÐÄÔàÖ®ÉÏ ¡£×óÓÒÐØÇ»¸÷ÓзÎÒ¶ £¬×ó¶þÓÒÈý £¬ÓҷοÉÒÔ·ÖΪÉÏ¡¢ÖС¢ÏÂÈýÒ¶ £¬×ó·ÎÔò½öÓÐÉÏ¡¢ÏÂÁ½Ò¶ £¬ÒÔÊÇÈËÌåµÄ·ÎÒ»¹²ÓÐÎåÒ¶ ¡£Ã¿¸ö·ÎÒ¶Ö®¼äÓÐÐØĤÀë¸ô £¬¸÷×ÔÓÐÖ§Æø¹ÜÓëÖ÷Æø¹ÜÏàͨ £¬Ï໥֮¼äûÓÐÁªÏµ ¡£

ÿ´ÎºôÎü £¬¿ÕÆøͨ¹ý±ÇÇ»½øÈëÆø¹Ü £¬ÔÙ½øÈëÖ§Æø¹Ü ¡£Ö§Æø¹Ü·ÖΪ×óÓÒÖ÷¸ÉÖ§Æø¹Ü £¬Æä×é³ÉÓëÆø¹ÜÏàËÆ £¬²¢Öð½¥·ÖÖ¦³É¸üСµÄ·ÖÖ§¡ª¡ªÆø¹ÜÖ§Æø¹ÜÊ÷ £¬¶ÔÎüÈëµÄ¿ÕÆø¾ÙÐÐÖ¸µ¼¡¢¼ÓʪºÍ¼ÓÈÈ ¡£ÖÕÄ©Ö§Æø¹Ü×îºóÐγÉС·ÎÅÝ´Ø £¬·ÎÅÝ×ÜÊýµÖ´ïÊý°ÙÍò ¡£·ÎÅݱ»Ã«Ï¸Ñª¹ÜÍøËùÀ§ÈÆ ¡£Í¨¹ýëϸѪ¹ÜµÄ±¡Ä¤ £¬¿ÕÆøºÍѪҺ¾ÙÐÐÑõÆøºÍ¶þÑõ»¯Ì¼µÄ½»Á÷[1] ¡£

image.png

ͼ1 ºôÎüϵͳʾÒâͼ(Òý×Ôhttps://www.nhlbi.nih.gov/health-topics/how-lungs-work)

·ÎµÄϸ°û·ÖÐÍ

·Î²¿Ï¸°ûÊÇ·ÎÖ´ÐÐÐÄÀí¹¦Ð§µÄ»ù±¾µ¥Î» £¬Í¨¹ýÏàʶÆäÖÖÀàºÍ״̬ £¬ÈËÃÇ¿ÉÒÔ½øÒ»²½Ñо¿·Î²¿¼²²¡µÄ±¬·¢ÆøÀí £¬¾ÙÐÐ׼ȷÓÐÓõÄÖÎÁÆ ¡£Í¨¹ýÏÔ΢¾µÊÓ²ì £¬ÃâÒßÓ«¹â±ê¼ÇµÈ¹Å°åÒªÁì £¬ÒÑÖªÏþµÄÈËÌå·Î²¿Ï¸°ûÀàÐÍÓÐ45ÖÖ ¡£¶ø¿Æѧ¼Ò½èÖú¸Õ¸ÕÐËÆðµÄµ¥Ï¸°û²âÐòÊÖÒÕ £¬´ÓÁíÒ»¸öά¶È»æÖƳöÈËÌå¸ü¶àµÄ·Î²¿Ï¸°ûÖÖÀ༰±í´ï״̬ £¬È·¶¨Á˳ÉÈË·ÎÖÐÓÐ58ÖÖת¼Éϲî±ðµÄϸ°ûȺÌå £¬°üÀ¨15ÖÖÉÏƤϸ°û £¬9ÖÖÄÚƤϸ°û £¬9ÖÖ»ùÖÊϸ°û£¨Í¼2£©ºÍ25ÖÖÃâÒßϸ°û(ͼ3)[2] ¡£

image.png

ͼ2 ·Î²¿ÉÏƤϸ°û¡¢ÄÚƤϸ°ûºÍ»ùÖÊϸ°ûȺ·ÖÀ༰×é֯ѧ¶¨Î»[2]

¶ø¹éÄɳöµÄÕâ58ÖÖϸ°ûÖаüÀ¨41ÖÖÒÑÖªµÄ·Î²¿Ï¸°ûÀàȺ £¬²»°üÀ¨Ô­±¾±»ÒÔΪ±£´æµÄ4ÖÖϸ°û £¬¼´Éñ¾­Ôª¡¢Éñ¾­½ºÖÊ £¬´Ø״ϸ°ûÒÔ¼°ÊÈËáÁ£Ï¸°û ¡£¶Ô¸ÃÑо¿Ð§¹û¸ÐÐËȤµÄСͬ°é¿ÉÒÔÔÚ¹«ÖÚºÅÖÐË÷ÒªÔ­ÎÄ ¡£ÏÂÃ潫ÌôÑ¡Á½´óÀຬÁ¿×î¶àµÄ·Î²¿Ï¸°û£¨ÉÏƤϸ°ûºÍÄÚƤϸ°û£©×ö¼òÒªÏÈÈÝ ¡£

image.png

ͼ3 ·ÎÃâÒßϸ°û·ÖȺ[2]

·ÎÅÝÉÏƤϸ°û

·ÎÅÝÉÏƤϸ°û×÷ΪÆøÌå½»Á÷µÄµ¥Î»£¨Í¼4£© £¬Î¬³Ö×Å·ÎÔàµÄ»ù±¾¹¦Ð§ ¡£·ÎÅÝÉÏƤϸ°ûÖ÷ÒªÓÉIÐÍ·ÎÅÝÉÏƤϸ°û £¬¢òÐÍ·ÎÅÝÉÏƤϸ°û×é³É ¡£

·ÎÅÝIÐÍϸ°û £¬ÆäÍâò±ê¼ÇÎïÊÇˮͨµÀÂÑ°×5(AQP5)Õ¼·ÎÅÝÍâò»ýµÄ96% ¡£ÕâЩϸ°ûºÜÊDZ¡ £¬³ÊÁÛ×´ £¬ËüÃÇÓë·ÎëϸѪ¹ÜÄÚƤ¹²ÓÃÒ»¸ö»ùµ×Ĥ £¬ÐγÉÆøѪÆÁÕÏ £¬Ôڴ˱¬·¢ÆøÌå½»Á÷ ¡£

image.png

ͼ4 СÊó·ÎÅÝÇøʾÒâͼ[4]

IIÐÍϸ°ûΪÇòÐηÎϸ°û £¬ÆäÍâò±ê¼ÇÎïΪSFTPC£¨ÓÖ³ÆΪSPC£© £¬½öÕ¼·ÎÅÝÍâò»ýµÄ4% £¬µ«Õ¼·ÎÅÝÉÏƤϸ°ûµÄ60% £¬Õ¼ËùÓзÎϸ°ûµÄ10-15% ¡£¢òÐÍ·ÎÅÝϸ°ûλÓÚ·ÎÅݹսǴ¦ £¬¾ßÓкϳɡ¢Éø͸·ÎÍâò»îÐÔÎïÖʵĹ¦Ð§ £¬»¹¿Éµ÷Àí·ÎÅÝË®·Ö £¬¼æÓзֽâ³ÉIÐÍϸ°ûµÄ×÷ÓÃ[3] ¡£

·Î²¿ÄÚƤϸ°û

ÄÚƤϸ°ûλÓÚÉø͸Ôڷβ¿µÄѪ¹ÜÉÏ £¬Ëü²»µ«ÊÇѪҺ £¬¿ÕÆøºÍ»ùÖÊ×éÖ¯Ö®¼äµÄÎïÀíÆÁÕÏ £¬»¹¾ßÓдúл»îÐÔ £¬¼ÓÈëÑ×Ö¢¿ØÖÆ¡¢°×ϸ°ûÔËÊ䡢Ѫ¹ÜÌìÉúºÍѪ¹ÜÕÅÁ¦µÈÀú³Ì ¡£Æ¾Ö¤×îеĵ¥Ï¸°û²âÐòЧ¹û £¬·ÎÔàÄÚƤϸ°û¿É·ÖΪÁÜ°ÍÄÚƤϸ°û¡¢¶¯ÂöÄÚƤϸ°û¡¢Í¨Ë×ëϸѪ¹ÜÄÚƤϸ°û(General capillary, gCap )¡¢Æø¹Üϸ°û(Aerocyte)¡¢·Î¾²ÂöÄÚƤϸ°ûºÍÈ«Éí¾²ÂöÄÚƤϸ°û[5] ¡£

ÆäÖÐ £¬¼ÓÈëÆøÌå½»Á÷µÄÊÇ·ÎÅÝëϸѪ¹ÜÄÚƤϸ°û £¬ÓÉ¡°Æø¹Üϸ°û¡±ºÍͨË×ëϸѪ¹ÜÄÚƤϸ°ûÅäºÏ×é³É ¡£¡°Æø¹Üϸ°û¡±×¨ÃÅÓÃÓÚÆøÌå½»Á÷ºÍ°×ϸ°ûÔËÊä £¬ÊǷζÀÍ̵ÄÄÚƤϸ°û£»Í¨Ë×ëϸѪ¹ÜÄÚƤϸ°ûÓÃÓÚµ÷ÀíѪ¹ÜÊæËõÕÅÁ¦ £¬²¢ÔÚëϸѪ¹ÜÎÈ̬ºÍÐÞ¸´Öг䵱¸Éϸ°û/×æϸ°û£¨Í¼5£©[6] ¡£

image.png

ͼ5 ·ÎÅÝÆøÌå½»Á÷ʾÒâͼ[6]

ÄÏÄ£ÉúÎïÔÚСÊó·Î²¿Ï¸°ûÌض¨marker»ùÒòÖÐÇÃÈëCre/DreÖØ×éøԪ¼þ»ò±¨¸æ»ùÒò £¬Ñо¿Õß¿ÉÒÔ¶ÔÿÀàϸ°û¾ÙÐбê¼Ç £¬»¹¿ÉÒÔÔÚÌض¨Ï¸°ûȺÀï¾ÙÐлùÒò¼°Ï¸°û¹¦Ð§µÄÑо¿ ¡£Ïêϸģ×ÓÐÅÏ¢¼ûÏÂ±í£º

±í1 ·Î²¿Ìض¨Ï¸°û¹¤¾ßÊó

image.png

·Î²¿ÖØ´ó¼²²¡¶¯ÎïÄ£×ÓÏÈÈÝ

×÷ΪÖ÷ÒªµÄºôÎüÆ÷¹Ù £¬·Î²¿Ëæʱ»áÇÖÈëϸ¾ú¡¢²¡¶¾¡¢Õæ¾ú¡¢»Ò³¾µÈ £¬Ôì³É²î±ðÀàÐ͵ķβ¿¼²²¡ £¬ÈçйڷÎÑ× £¬´óÒ¶ÐÔ·ÎÑ× £¬Ö§Æø¹ÜÑ×µÈ £¬ÑÏÖصĿɵ¼Ö¼±ÐÔ»òÂýÐÔºôÎüË¥½ß¼°ÖÖÖַΰ© ¡£ÏÖÔÚ £¬ÈËÃǶÔÕâЩ¼²²¡·¢²¡»úÖÆ»¹²»·óÏàʶ £¬Òò´ËÖÎÁƲ½·¥Ê®·Öȱ·¦ ¡£ÎªÉîÈëÑо¿¼²²¡µÄ±¬·¢Éú³¤ £¬Ïà¹ØÑо¿¶¯ÎïÄ£×ӵĹ¹½¨ÊDZز»¿ÉÉÙµÄÒ»»· ¡£

йڷÎÑ×Ñо¿Ä£×Ó

×ÔйÚÒßÇ鱬·¢ÒÔÀ´ £¬×èÖ¹2021Äê11ÔÂ8ÈÕ £¬È«ÇòйڷÎÑ×ÀÛ¼ÆÈ·ÕﲡÀýÒѾ­Áè¼Ý2.5ÒÚÀý £¬È«ÇòÀÛ¼ÆéæÃü²¡ÀýÁè¼Ý505ÍòÀý ¡£

ACE2 ÊÇ´Ë´Îйڲ¡¶¾Ñ¬È¾ÈËÌåµÄÖ÷Ҫ͎áÊÜÌå ¡£Ð¹ڲ¡¶¾µÄ´ÌÍ»ÌÇÂѰ׿ÉÒÔÓë·ÎÉÏƤϸ°ûϸ°ûĤÉ쵀 ACE2ÌØÒìÐÔµÄÍŽá ¡£Í¨¹ýÖ¬ÖÊ°ûĤµÄÄÚÍÌ×÷Óà £¬²¡¶¾¿ÅÁ£ÓëÄÒÅÝÈںϲ¢¿ìËÙ½øÈëËÞÖ÷ϸ°ûÄÚ[7] ¡£µ«Ð¡Êóϸ°û²»¾ßÓÐÍŽáйڲ¡¶¾ÂÑ°×µÄÄÜÁ¦ £¬Òò´Ë¿ÉÒÔ½«ÈËACE2µÄתÈ뵽СÊóÌåÄÚ £¬ÕâÖÖСÊóѬȾSARS-CoV-2ºóµÄ³¦µÀ¡¢·ÎÑ×Ö¢×´¼°²¡ÀíѧÌØÕ÷ÓëCOVID-19»¼ÕߺÜÏàËÆ[8] ¡£ÄÏÄ£ÉúÎï×ÔÖ÷Ñз¢ÁËCAG-hACE2-IRES-Luc-Tg(hACE2-Tg) СÊó £¬¿ÉÒÔ×÷ΪÒßÃçºÍÒ©ÎïÑз¢µÄÖ÷Òª¹¤¾ß ¡£ÏêϸÏÈÈݿɼûÍùÆÚÍÆÎÄ£ºÑ¬È¾²¡Ñо¿É±ÊÖﵡª¡ª³£Óö¯ÎïÄ£×ÓÏÈÈÝ

ÂýÐÔÛÕ±ÕÐÔ·ÎÑ×Ñо¿Ä£×Ó

ÂýÐÔÛÕ±ÕÐÔ·ÎÑ×£¨chronic obstructive pulmonary emphysema £¬COPD£©ÓÖ³ÆÛÕ±ÕÐÔ·ÎÆøÖ× £¬¾ßÓÐÖÕĩϸ֧Æø¹ÜÔ¶¶Ë²¿·Ö£¨°üÀ¨ºôÎüÐÔϸ֧Æø¹Ü¡¢·ÎÅݹܡ¢ ·ÎÅÝÄҺͷÎÅÝ£©ÅòÕÍ £¬²¢°éÓÐÆøÇ»±ÚµÄÆÆËðµÄÌåÏÖ ¡£ÏÖÔÚ £¬ÎÒ¹úÂý×è·Î»¼ÕßÈËÊýÔ¼1ÒÚ £¬ÒѾ­³ÉΪÓë¸ßѪѹ¡¢ÌÇÄò²¡¡°»ìΪһ̸¡±µÄÂýÐÔ¼²²¡ £¬×é³ÉÖØ´ó¼²²¡¼ç¸º[9] ¡£

image.png

ͼ6 Õý³£µÄ·ÎÅݺÍËðÉ˺óµÄ·ÎÅݱÈÕÕͼ £¬ËðÉ˺óµÄ·ÎÅÝʧȥµ¯ÐÔ²¢Ì«¹ýÅòÕÍ(ͼƬÀ´×ÔÍøÂç)

ͨÀýCOPDÓÕµ¼Ä£×Ó

ÏÖÔÚ×î³£ÓõÄCOPD¶¯ÎïÄ£×ÓÊÇСÊó ¡£Í¨¹ýÔÚÏãÑÌÑÌÎíÖÐ̻¶ 6¸öÔ £¬Ð¡ÊóÏÔʾ³öÈËÀàCOPDµÄһЩÌØÕ÷ £¬ÈçÂýÐԷβ¿Ñ×Ö¢¡¢ÖжÈÆøµÀÀ©ÔöºÍÇá¶ÈСÆøµÀÏËά»¯[10] ¡£±ðµÄ £¬Í¨¹ýµ¯ÐÔÂÑ°×ø¾ÙÐÐÆø¹ÜµÎ×¢¡¢Î¢ÉúÎï¼°Æä²úÆ·ÓÕµ¼»òÕßÆäËû»¯Ñ§ÎïÖÊÓÕµ¼ £¬Ò²Óй¹½¨ÀֳɵÄÏÈÀý[11] ¡£

»ùÒòÐÞÊÎCOPD×Ô¾õÄ£×Ó

Ëæ×Å»ùÒòÐÞÊÎÊÖÒÕµÄÉú³¤ £¬Í¨¹ýµ÷¿ØCOPDÏà¹Ø»ùÒòµÄ±í´ï £¬½¨Éè»ùÒò¹¤³ÌСÊóÄ£×ÓµÄÓ¦ÓóÊÉÏÉýÇ÷ÊÆ ¡£Íâò»îÐÔ¼ÁÂÑ°×(Surfactant protein, SP)-DÊÇÒ»ÖÖģʽʶ±ð·Ö×Ó £¬ÊôÓÚ½ºÔ­Äý¼¯ËØÂÑ°×¼Ò×å ¡£SP-DµÄÖ÷Òª¹¦Ð§ÊÇÍŽᲡԭ΢ÉúÎï»òÕß¼ÄÉú³æ £¬ÕâЩÉúÎïͨ¹ýµ÷Àí×÷Óñ»ÖÐÐÔÁ£Ï¸°ûɨ³ý £¬´Ó¶ø±»ÍÌÊÉϸ°ûʶ±ð ¡£ÁÙ´²Öз¢Ã÷¾ßÓнϸߵÄSP-DˮƽµÄ»¼Õß £¬ÆäÒòCOPD±¬·¢µÄΣº¦½ÏµÍ £¬·Î¹¦Ð§Ï½µËÙÂʽϻºÂý ¡£Sftpd»ùÒò£¨±àÂëSP-DÂÑ°×£©ÇóýСÊó¿É·ºÆð·ÎÆøÖס¢¾ÙÐÐÐÔ¸ôĤ±Úºñ¶ÈºÍÐØĤÏÂÏËά»¯ £¬ÌáÐÑÕâЩ¶¯Îï·ºÆð·ÎÄÚ·ÎÆøÖ׺ÍÏËά»¯µÄÍŽá±íÐÍ[12] ¡£

COPD°ÐµãÑо¿Ä£×Ó

IL-17aÊÇCOPDÖÐÐÔÁ£Ï¸°ûÆøµÀÑ×Ö¢µÄÒªº¦½éÖÊ ¡£Éý¸ßµÄѪÇåIL-1¦ÂºÍ IL-17aˮƽ¿É×÷ΪCOPDÒ»Á¬ÐÔÖÐÐÔÁ£Ï¸°ûÆøµÀÑ×Ö¢ºÍDZÔÚÒ»Á¬¶ñ»¯µÄÉúÎï±ê¼ÇÎï ¡£×è¶ÏIL17a/IL17RA¿ÉÓÐÓýµµÍÏãÑÌÑÌÎíÓÕµ¼µÄMUC5ACÂѰס¢IL6¡¢TNF¦ÁºÍIL-1¦ÂµÈÑ×Ö¢Òò×ÓÔÚÖ§Æø¹ÜÉÏƤϸ°ûÖеıí´ï ¡£ÔÚСÊóÌåÄÚÌØÒìÐÔÇóýIL17aÔòÓÐÒæÓÚïÔÌ­ÖÐÐÔÁ£Ï¸°ûÏòÆøµÀµÄÕÙļ[13] ¡£ÕâЩЧ¹ûÌáÐÑ°ÐÏòIL17aÊÇDZÔÚµÄCOPDÖÎÁÆÊֶΠ¡£

COPD»¼Õß³ýÁËÏÔ×ŵķβ¿ÌØÕ÷Ö®Íâ £¬»¹±£´æÌåÖؼõÇáµÄ״̬ ¡£ÁÙ´²ÉÏ·¢Ã÷ £¬COPD»¼ÕßµÄ̵ҺºÍѪÇåÖеİ×ϸ°û½éËØ-6 (IL-6)ˮƽ½Ï¸ß ¡£Òò´Ë £¬¿Æѧ¼Òͨ¹ý¹¹½¨IL6ÇóýСÊó £¬ÓëÒ°ÉúÐ;ÙÐбÈÕÕ £¬ÑéÖ¤IL6¶ÔCOPD¼²²¡±¬·¢µÄÓ°Ïì ¡£Ñо¿Ð§¹û·¢Ã÷ £¬Ò°ÉúÐÍСÊóºÍ IL£¶ÇóýСÊóͬʱ¾ÙÐÐÏãÑÌÑÌÎí̻¶ £¬IL6ÇóýСÊó¾ßÓнϵ͵ÄÌåÖØ £¬ÑªÇåÊÝËØˮƽºÍÖ¬·¾×éÖ¯ÖÊÁ¿ £¬ÌáÐÑIL-6¿É×÷ΪÌåÖصĵ÷ÀíÒò×Ó[14] ¡£

ÄÏÄ£ÉúÎï¿ÉÌṩCOPDÏà¹Ø»ùÒò¼°ÖÎÁưеãÇóýСÊóºÍÈËÔ´»¯Ð¡Êó £¬ÖúÁ¦COPDÏà¹ØÑо¿£¨¼ûÎÄÄ©±í3£© ¡£

Ïø´­Ñо¿Ä£×Ó

Ïø´­ÓÖÃûÖ§Æø¹ÜÏø´­ ¡£Ö§Æø¹ÜÏø´­ÊÇÓɶàÖÖϸ°û¼°Ï¸°û×é·Ö¼ÓÈëµÄÂýÐÔÆøµÀÑ×Ö¢ ¡£ÏÖÔÚ¶ÔÏø´­µÄ»ù´¡²¡ÒòÉв»¿ÉÍêÈ«Ïàʶ ¡£î¾»¼Ïø´­µÄ×î´óΣº¦ÒòËØÊÇÒÅ´«Ò׸ÐÐÔÓëÇéÐνӴ¥£¨ÎüÈë¿ÉÄÜÓÕ·¢¹ýÃô·´Ó¦»ò´Ì¼¤ÆøµÀµÄÎïÖʺͿÅÁ££©¶þÕßµÄÍŽá £¬ÕâÀàÎïÖʺͿÅÁ£°üÀ¨ÊÒÄÚ¹ýÃôÔ´£¨ÀýÈç¼ÒÍ¥³¾òý£©¡¢ÊÒÍâ¹ýÃôÔ´£¨ÀýÈ绨·Û£©ºÍÑ̲ÝÑÌÎíµÈ[15] ¡£

image.png

ͼ7 Ïø´­±¬·¢µÄÖ¢×´ºÍÖÂÃôÔ´

³¾òý£¨HDM£©ÊÇÎݳ¾¹ýÃôµÄÖ÷Òª¹ýÃôÔ´ ¡£ÔÚÒÑÓеÄÑо¿ÖÐ֤ʵÎú³¾òýÔÚÏø´­µÄÉú³¤Öм°ÓÕ·¢ÆäËû¹ýÃôÐÔ¼²² ¡£¨ÈçƤÑ׺ͱÇÑ×£©ÖÐÆðÖ÷Òª×÷ÓÃ[16] ¡£HDMµÄ·à±ã¿ÅÁ£Öк¬ÓжàÖÖ¹ýÃôÔ­ £¬ÕâЩ¹ýÃôÔ­ÊÇÈ«ÌìϹýÃôÐÔÏø´­µÄÖ÷ÒªÓÕÒò £¬¿Éͨ¹ý¾Ö²¿Ê¹ÓÃHDM¿ª·¢¾ßÓÐÁÙ´²Ïà¹ØÒâÒåµÄСÊóÄ£×Ó ¡£ÄÏÄ£ÉúÎï¿ÉÌṩ³¾òýÓÕµ¼µÄÏø´­Ä£×Ó £¬ÏêϸÑéÖ¤Êý¾ÝÈçÏ ¡£Í¼1ΪҰÉúÐÍC57BL/6СÊó¾­³¾òýÓÕµ¼ºóÃâÒßϸ°ûÊýĿת±äµÄЧ¹û £¬±ÈÕÕ×éСÊóÏà±È £¬ÖÐÐÄÁ£Ï¸°û¡¢ÁÜ°Íϸ°ûºÍÊÈËáÐÔϸ°ûµÄÊýÄ¿ÓÐÏÔ×ŵÄÔöÌí ¡£

image.png

ͼ8 C57BL/6СÊóÔÚ³¾òýÓÕµ¼ºóÖÖÖÖÃâÒßϸ°ûÊýÄ¿µÄת±ä

¾ø´ó´ó¶¼Ïø´­»¼Õß±¬·¢Ê±¿Éͨ¹ý¿¹Ñס¢Æ½´­µÈ¹Å°åÖÎÁÆÒ©Îï»ñµÃ¿ØÖÆ £¬µ«ÈÔÓв¿·Ö»¼ÕߵIJ¡ÇéÐèÒª½èÖúÈ«ÉíÓ¦Óø߼ÁÁ¿¼¤Ëزſɻº½â»òÈÔÎÞ·¨¿ØÖÆ £¬ÉõÖÁÍþвÉúÃü ¡£½üÄêÀ´ £¬Õë¶ÔÕâЩÄÑÖÎÐÔÖØÖ¢Ïø´­ £¬ÈËÃÇ¿ª·¢ÁËеİÐÏòÒ©Îï²¢Ó¦ÓÃÓÚÁÙ´² ¡£ÏÖÔÚÒÑÉÏÊеİÐÏòÒ©ÓаÂÂíÖéµ¥¿¹£¨¿¹IgE£© £¬IL-5/IL-5Rµ¥¿¹ ¡£¸ßDZÁ¦ÔÚÑеÄÖضÈÏø´­Ò©ÎïÓÐIL-4/IL-13µ¥¿¹£»TSLP¿¹Ì壻IL-33/ST-2µ¥¿¹µÈ ¡£ÄÏÄ£ÉúÎï¿ÉÌṩÏìÓ¦°ÐµãµÄÈËÔ´»¯Ð¡Êó £¬ÖúÁ¦°ÐÏòÁ¢ÒìÒ©ÎïµÄÑз¢ºÍɸÑ ¡£¨¼ûÎÄÄ©±í3£© ¡£

·Î°©Ñо¿Ä£×Ó

·Î°©ÊÇÆðÔ´ÓÚÉÏƤ×éÖ¯µÄ¶ñÐÔÖ×Áö £¬ÔÚÎÒ¹úÖÖÖÖ¶ñÐÔÖ×ÁöÖз¢²¡ÂʺÍéæÃüÂʾùÅÅÃûµÚÒ» £¬ºÃ·¢ÄêËêÔÚ70ËêÒÔÉÏ £¬ÄÐÅ®·¢²¡ÂÊÖ®±ÈΪ2£º1 ¡£ÓÉÓÚ¿ÕÆøÎÛȾ¡¢·ÅÉäÐÔ̻¶ÒÔ¼°·Î²¿Õæ¾úѬȾµÈÔµ¹ÊÔ­ÓÉ £¬Ê¹µÃ·Î°©µÄ·¢²¡ÂʺÍéæÃüÂʾþӲ»Ï ¡£·Î°©Ö÷Òª·ÖΪ·ÇСϸ°û·Î°©£¨non small cell lung cancer, NSCLC£©ºÍСϸ°û·Î°©£¨small celllung cancer, SCLC£© £¬ÆäÖзÇСϸ°û·Î°©Ô¼Õ¼·Î°©µÄ80~85%[17] ¡£ÔÚ·ÇСϸ°û·Î°©ÖÐ £¬·¢Ã÷Ðí¶àÇý¶¯Í»±ä £¬³£¼ûµÄÇý¶¯Í»±ä°üÀ¨KrasÍ»±ä¡¢EGFRÍ»±ä¡¢FGFR1À©Ôö¡¢ALKÖØÅÅ¡¢HER2Í»±ä¡¢METÀ©Ôö¡¢BRAFÍ»±äµÈ[17] ¡£Ñо¿Ö°Ô±¶Ô·Î°©µÄ¶à¸öÍ»±ä¾ÙÐÐ̽ÌÖ £¬½«·Î°©Öз¢Ã÷µÄÍ»±ä½øÈëÒýÈ뵽СÊóÖÐ £¬´Ó¶ø»ñµÃ¶àÖÖÓÃÓÚÑо¿·Î°©±¬·¢ÓëתÒÆ»úÖÆ¡¢É¸Ñ¡ºÍÆÀ¼Û¿¹Ö×ÁöÒ©ÎïµÄ·Î°©Ä£×Ó ¡£

±í2 ·ÇСϸ°û·Î°©ÖлùÒòÍ»±äƵÂʺÍÀàÐÍ[17]

image.png

ÏÖÔÚ¹ú¼ÊÉÏÓ¦ÓÃ×îÆÕ±éµÄ·Î°©¶¯ÎïÄ£×Ó¾ÍÊÇKras-LSL-G12DСÊóÄ£×Ó £¬¿ÉÒÔͨ¹ýÓë·ÎÉÏƤϸ°ûÌØÒìÐÔµÄCreת»ùÒòСÊóÔÓ½»À´ÊµÏÖKrasÍ»±äÌåµÄ¼¤»î £¬´Ó¶øµ¼Ö·ΰ©µÄ±¬·¢ ¡£ÄÏÄ£ÉúÎïÌṩµÄKras(LSL-G12D/+)СÊóƷϵÔÚKrasÍ»±ä»ùÒòµÄÉÏÓβåÈëÁËloxp-stop-loxpÖÕÖ¹ÐòÁÐ £¬ÆäÔÚûÓÐcreÖØ×éøµÄÌõ¼þÏÂÊDz»±í´ïµÄ ¡£Cre½éµ¼µÄÖØ×é¿ÉÈ¥³ýÖÕÖ¹ÃÜÂë×Ó £¬Ê¹Ö°©»ùÒò±í´ï ¡£½ÓÄÉÏÙ²¡¶¾ÔØÌåЯ´øCreѬȾ·Î²¿Ï¸°ûºó £¬µ¼Ö·ÎÖ×Áö±¬·¢µÄƵÂʺÜÊǸߣ¨Í¼8£© ¡£

image.png

ͼ9 ½ÓÄÉÆø¹ÜÄÚ×¢ÉäµÄÒªÁì £¬½«AAV-cre²¡¶¾×¢É䵽СÊó·Î²¿ £¬3¸öÔºó¶ÔСÊó·Î²¿¾ÙÐÐCT¼ì²â £¬CTЧ¹ûÏÔʾÓÐÏÔ×ŵÄÖ×ÁöµÄÐγÉ ¡£

±ðµÄ £¬ÎÒÃÇ»¹¿ÉÒÔÌṩKras(LSL-G12D/+)СÊóÖ×Áöϸ°ûȪԴµÄͬϵºÉÁöСÊóÄ£×Ó ¡£Ö×Áöϸ°û¿ÉÔÚÊÜÌåСÊóÌåÄÚ¿ìËÙÔöÖ³£¨Èçͼ9£© ¡£ºÉÁöСÊóÄ£×Ó¿ÉÌá¸ßÁÙ´²Ò©Ð§ÆÀ¼ÛʵÑé²Ù×÷µÄÇáÓ¯ÐÔ ¡£

image.png

ͼ10  ºÉÁöСÊóÌåÄÚÖ×Áöϸ°ûÌå»ýËæʱ¼äÔöÌíµÄת±ä

¹ØÓڷΰ©µÄÏêϸÏÈÈݿɼûÍùÆÚÍÆÎÄ£º»ùÒò¹¤³ÌСÊó¼²²¡Ä£×ÓϵÁСª¡ª·Î°©Æª

ÄÏÄ£ÉúÎï·Î²¡¶¯ÎïÄ£×Ó

ÄÏÄ£ÉúÎï×ÔÖ÷¹¹½¨Á˶àÖÖ»ùÒòÐÞÊÎСÊ󣨱í3£© £¬¿ÉÒÔÓÃÓÚйڷÎÑס¢ÂýÐÔÛÕ±ÕÐÔ·ÎÑס¢Ïø´­¡¢·Î°©µÈ¼²²¡µÄÑо¿ºÍÒ©Îïɸѡ ¡£

±í3 ·Î²¿¼²²¡Ïà¹Ø¶¯ÎïÄ£×ÓÁбí

ÄÏÄ£ÉúÎïÉî¸û»ùÒò±à¼­ÁìÓò £¬Ìṩȫ·½Î»Ä£Ê½ÉúÎïЧÀÍ £¬°üÀ¨»ùÒòÐÞÊÎÖÆÆ·Ä£×Ó¹©Ó¦¡¢¸öÐÔ»¯Ä£×Ó¶¨ÖÆ¡¢ËÇÑø·±Óý¡¢±íÐÍÆÊÎö¡¢Ò©Ð§ÆÀ¼ÛµÈ £¬Öª×ã²î±ðʵÑéÊÒÐèÇó ¡£

Reference:

[1] https://www.nhlbi.nih.gov/health-topics/how-lungs-work

[2] Travaglini KJ, Nabhan AN, Penland L, et al. A molecular cell atlas of the human lung from single-cell RNA sequencing. Nature. 2020 Nov;587(7835):619-625.

[3] https://www.ncbi.nlm.nih.gov/books/NBK557542/

[4] Hogan B.L.M. (2020) The Alveolar Stem Cell Niche of the Mammalian Lung. In: Nakanishi T., Baldwin H., Fineman J., Yamagishi H. (eds) Molecular Mechanism of Congenital Heart Disease and Pulmonary Hypertension. Springer, Singapore. https://doi.org/10.1007/978-981-15-1185-1_2

[5] Schupp JC, Adams TS, Cosme C Jr, et al. Integrated Single-Cell Atlas of Endothelial Cells of the Human Lung. Circulation. 2021 Jul 27;144(4):286-302. doi: 10.1161/CIRCULATIONAHA.120.052318.

[6]Gillich A, Zhang F, Farmer CG, Travaglini KJ, Tan SY, Gu M, Zhou B, Feinstein JA, Krasnow MA, Metzger RJ. Capillary cell-type specialization in the alveolus. Nature. 2020 Oct;586(7831):785-789. doi: 10.1038/s41586-020-2822-7.

[7] Bohn MK, Hall A, Sepiashvili L, Jung B, Steele S, Adeli K. Pathophysiology of COVID-19: Mechanisms Underlying Disease Severity and Progression. Physiology (Bethesda). 2020 Sep 1;35(5):288-301.

[8] Jiang RD, Liu MQ, Chen Y, et al. Pathogenesis of SARS-CoV-2 in Transgenic Mice Expressing Human Angiotensin-Converting Enzyme 2. Cell. 2020 Jul 9;182(1):50-58.e8.

[9]Wang C, Xu J, Yang L, Xu Y, et al; China Pulmonary Health Study Group. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet. 2018 Apr 28;391(10131):1706-1717.

[10]Churg A, Cosio M, Wright JL. Mechanisms of cigarette smoke-induced COPD: insights from animal models[ J]. Am J Physiol Lung Cell Mol Physiol, 2008, 294(4): L612-L631£®

[11]ÀîÀöÇò, лÀö»ª, ËïÊ¥»ª. ÂýÐÔÛÕ±ÕÐԷμ²²¡¶¯ÎïÄ£×ÓµÄÑо¿Ï£Íû[J]. ÖÐÄÏ´óѧѧ±¨£ºÒ½Ñ§°æ, 2017, 42(9):6.

[12] Barreiro E, Wang X, Tang J. COPD: preclinical models and emerging therapeutic targets. Expert Opin Ther Targets. 2019 Oct;23(10):829-838. doi: 10.1080/14728222.2019.1667976. Epub 2019 Sep 20. PMID: 31512957.

[13] Wu M, Lai T, Jing D,et al. Epithelium-derived IL17A Promotes Cigarette Smoke-induced Inflammation and Mucus Hyperproduction. Am J Respir Cell Mol Biol. 2021 Jun 29.

[14] Pauwels NS, Bracke KR, Maes T, et al. The role of interleukin-6 in pulmonary and systemic manifestations in a murine model of chronic obstructive pulmonary disease. Exp Lung Res. 2010 Oct;36(8):469-83.

[15]https://www.who.int/zh/news-room/fact-sheets/detail/asthma

[16]Tang W, Dong M, Teng F, Cui J, Zhu X, Wang W, Wuniqiemu T, Qin J, Yi L, Wang S, Dong J, Wei Y. Environmental allergens house dust mite-induced asthma is associated with ferroptosis in the lungs. Exp Ther Med. 2021 Dec;22(6):1483.

[17]Min-chul Kwon, Anton Berns. Mouse models for lung cancer. MOLECULAR ONCOLOGY 7 (2013) 165e177.

ÉÏһƪ£ºÑ×֢СÌåNLRP3ÐźÅͨ· ÏÂһƪ£ºSNPÑо¿È«¹¥ÂÔ¡ª¡ª´ÓÁÙ´²µ½¶¯ÎïÄ£×Ó

Ïà¹ØÔĶÁ ¸ü¶à>>

²ÂÄúϲ»¶¸ü¶à>>

¶¯ÎïÊÔÑé

ÁÙ´²Åàѵ

Ä¥Á·¼°²¡Àí

ÁÙ´²ÊÔÑé

²úÆ·×¢²á

 

ÌìÏÂÃâ·Ñ×Éѯ:

ÓªÒµ×Éѯ£º17312606166£¨É¡Ë¾Àí£©

½Ú¼ÙÖµ°à£º17312606166£¨Î¢Ðźţ©

ÁªÏµµØµã£º
ËÕÖÝ£ºËÕÖÝÊÐËÕÖݹ¤ÒµÔ°ÇøʤÆÖ½ÖµÀÐËÆÖ·200ºÅ
Ì©ÖÝ£º½­ËÕÊ¡Ì©ÖÝÊÐÒ½Ò©¸ßÐÂÇøÐãˮ·20ºÅ19´±
¹ãÖÝ£º¹ãÖÝÊÐÀóÍåÇø»¨µØ´óµÀÖÐ228ºÅ

Copyright © 2018-2024 ÌÚ²©»á¹ÙÍø      ICP±¸°¸£ºËÕICP±¸17068211ºÅ Ö§³Öµ¥Î»£ºÌÚ²©»á¹ÙÍø

ÔÚÏß
¿Í·þ

ÊÖÒÕÔÚÏßЧÀÍʱ¼ä£º9:00-20:00

ÔÚÌÚ²©»á¹ÙÍø £¬Äú¶Ô½ÓµÄÊÇÊÖÒÕÖ°Ô± £¬¶ø·Ç¿Í·þ´«»°£¡

  • ´ó¶¯ÎïÊÔÑé
  • ÁÙ´²Åàѵ
  • ×éÖ¯²¡Àí
  • ÁÙ´²ÊÔÑé
  • ²úÆ·×¢²á
  • ¿ÆÑпÎÌâ

µç»°
×Éѯ


7*24Сʱ¿Í·þÈÈÏß

17312606166
ÏîĿ˾ÀíÊÖ»ú

΢ÐÅ
×Éѯ

¼Ó΢ÐÅ»ñÈ¡¶Ô½Ó
¡¾ÍøÕ¾µØͼ¡¿¡¾sitemap¡¿